AMPE
Ampio Pharmaceuticals Inc.
AMPE
AMPE
Delisted
AMPE was delisted on the 12th of April, 2024.
128 hedge funds and large institutions have $22.8M invested in Ampio Pharmaceuticals Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 32
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
128
Holding in Top 10
–
Calls
$674K
Puts
$77K
Top Buyers
| 1 | +$444K | |
| 2 | +$168K | |
| 3 | +$157K | |
| 4 |
Millennium Management
New York
|
+$55.6K |
| 5 |
NWM
Northcape Wealth Management
Williamsville,
New York
|
+$46K |
Top Sellers
| 1 | -$2.95M | |
| 2 | -$2.43M | |
| 3 | -$524K | |
| 4 |
BIAS
Beacon Investment Advisory Services
Morristown,
New Jersey
|
-$97K |
| 5 |
Barclays
London,
United Kingdom
|
-$90.2K |